![](/img/cover-not-exists.png)
Promises and limitations of nanoparticles in the era of cell therapy: Example with CD19-targeting chimeric antigen receptor (CAR)-modified T cells
Jakobczyk, Hélène, Sciortino, Flavien, Chevance, Soizic, Gauffre, Fabienne, Troadec, Marie-BérengèreLanguage:
english
Journal:
International Journal of Pharmaceutics
DOI:
10.1016/j.ijpharm.2017.07.075
Date:
July, 2017
File:
PDF, 1.27 MB
english, 2017